MA38102A1 - Novel compounds used as inhibitors of diacylglycerol acyltransferase - Google Patents

Novel compounds used as inhibitors of diacylglycerol acyltransferase

Info

Publication number
MA38102A1
MA38102A1 MA38102A MA38102A MA38102A1 MA 38102 A1 MA38102 A1 MA 38102A1 MA 38102 A MA38102 A MA 38102A MA 38102 A MA38102 A MA 38102A MA 38102 A1 MA38102 A1 MA 38102A1
Authority
MA
Morocco
Prior art keywords
inhibitors
novel compounds
dgat1
compounds used
diacylglycerol acyltransferase
Prior art date
Application number
MA38102A
Other languages
French (fr)
Other versions
MA38102B1 (en
Inventor
Mui Cheung
Raghuram S Tangirala
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Priority claimed from PCT/US2013/071376 external-priority patent/WO2014081994A1/en
Publication of MA38102A1 publication Critical patent/MA38102A1/en
Publication of MA38102B1 publication Critical patent/MA38102B1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne de nouveaux composés qui sont des inhibiteurs d'acyl-coenzyme a: diacylglycérol transférase 1 (dgat1), des compositions pharmaceutiques les contenant, des procédés pour leur préparation, ainsi que leur utilisation en thérapie, seuls ou en combinaison avec des thérapies de gestion du poids ou autre thérapie de diminution des triglycérides pour la prévention ou le traitement de maladies liées à un dysfonctionnement de dgat1 ou dans lesquelles une modulation de l'activité de dgat1 peut avoir un bénéfice thérapeutique.The invention relates to novel compounds which are acyl-coenzyme a: diacylglycerol transferase 1 (dgat1) inhibitors, pharmaceutical compositions containing them, processes for their preparation and their use in therapy, alone or in combination with weight management therapies or other triglyceride lowering therapy for the prevention or treatment of diseases related to dgat1 dysfunction or in which modulation of dgat1 activity may be of therapeutic benefit.

MA38102A 2013-10-25 2013-11-22 Novel compounds used as inhibitors of diacylglycerol acyltransferase MA38102B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3172DE2013 2013-10-25
PCT/US2013/071376 WO2014081994A1 (en) 2012-11-23 2013-11-22 Novel compounds as diacylglycerol acyltransferase inhibitors

Publications (2)

Publication Number Publication Date
MA38102A1 true MA38102A1 (en) 2016-11-30
MA38102B1 MA38102B1 (en) 2017-11-30

Family

ID=58501200

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38102A MA38102B1 (en) 2013-10-25 2013-11-22 Novel compounds used as inhibitors of diacylglycerol acyltransferase

Country Status (1)

Country Link
MA (1) MA38102B1 (en)

Also Published As

Publication number Publication date
MA38102B1 (en) 2017-11-30

Similar Documents

Publication Publication Date Title
MA38949A1 (en) Saline form of hydrochloride for inhibition of ezh2
MA45985A (en) DIACYLGLYCEROL ACYLTRANSFERASE 2 INHIBITORS
MA40290A1 (en) Immune-regulating agents
MA38380A1 (en) Quinazoline inhibitors of activation of mutant forms of epidermal growth receptor (EGFR)
MA35459B1 (en) Compounds and compositions that can be used as c-kit kinase inhibitors
MA35460B1 (en) Compounds and compositions as c-kit kinase inhibitors
MA39211A1 (en) Tricyclic compounds as anti-cancer agents
MA37975B2 (en) Glucosylceramide synthase inhibitors
MA39219B1 (en) New lrrk2 Kinase Inhibitor Compounds Used to Treat Parkinson's, Alzheimer's and Amyotrophic Lateral Sclerosis
MA38810A1 (en) Inhibitors of rorc2 related methods of use
MA35753B1 (en) Aryl-dihydropyridinones and piperidinones as mgat2 inhibitors
GEP20237541B (en) Methods for treating and/or preventing graft-versus-host disease and/or diffuse alveolar hemorrhage and/or veno-occlusive disease associated with hematopoietic stem cell transplant
MX2019004859A (en) Combination treatments comprising administration of imidazopyrazinones.
MA43918A (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF ATOPIC DERMATITIS CONTAINING AN IL-31 ANTAGONIST AS ACTIVE SUBSTANCE
MA38190A2 (en) Autotaxin inhibitors
MA50406B1 (en) Magl pyrazole inhibitors
MA46611B1 (en) Combination therapies including imidazopyrazinones for the treatment of psychiatric and / or cognitive disorders
MA39447A1 (en) (s) -pirlindole or its pharmaceutically acceptable salts for use in medicine
MA37700B1 (en) N- [4- (quinolin-4-yloxy) cyclohexyl (methyl)] (hetero) arylcarboxamides for use as androgen receptor antagonists, their production and their use as medicaments
MA39448B1 (en) (r) -pirlindole and its pharmaceutically acceptable salts for medical use
MA38102A1 (en) Novel compounds used as inhibitors of diacylglycerol acyltransferase
PH12015501109A1 (en) Novel compounds as diacylglycerol acyltransferase inhibitors
FR3038605B1 (en) VICINAL PRIMARY DIAMINS ASSOCIATED WITH CHELATING MOTIFS OF METALS AND / OR FREE RADICALS, ACTIVE AGAINST CARBONYL AND OXIDIZING STRESSES AND THEIR USE
MA45990B1 (en) Combination of histamine-3 receptor inverse agonists with acetylcholinesterase inhibitors
MA46625B1 (en) LSD1 INHIBITORS AND THEIR MEDICAL USES